In patients undergoing mitral valve replacement for severe MR due to myxomatous degeneration, immunohistochemistry of IL-33 and ST2 are expressed in both valve interstitial cells (VICs) and valve endothelial cells (VECs) of the resected leaflets [83]. Here, IL1RL1 is linked to miotic rate.